Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
JA Burger, A Wiestner - Nature Reviews Cancer, 2018 - nature.com
B cell receptor (BCR) signalling is crucial for normal B cell development and adaptive
immunity. BCR signalling also supports the survival and growth of malignant B cells in …
immunity. BCR signalling also supports the survival and growth of malignant B cells in …
Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo-and immunotherapies
Tumor-associated macrophages (TAMs) play a central role in tumor progression, metastasis,
and recurrence after treatment. Macrophage plasticity and diversity allow their classification …
and recurrence after treatment. Macrophage plasticity and diversity allow their classification …
Nanomedicines for the treatment of hematological malignancies
AK Deshantri, AV Moreira, V Ecker… - Journal of controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
Chronic lymphocytic leukemia
N Chiorazzi, SS Chen, KR Rai - Cold Spring …, 2021 - perspectivesinmedicine.cshlp.org
Patients with chronic lymphocytic leukemia can be divided into three categories: those who
are minimally affected by the problem, often never requiring therapy; those that initially …
are minimally affected by the problem, often never requiring therapy; those that initially …
Targeting the tumor microenvironment of leukemia and lymphoma
UE Höpken, A Rehm - Trends in cancer, 2019 - cell.com
Despite progress in exploiting therapeutically the genetic vulnerabilities of leukemia and
lymphoma, the outcome is often extended progression-free survival but not tumor …
lymphoma, the outcome is often extended progression-free survival but not tumor …
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
To identify new therapeutic targets in acute myeloid leukemia (AML), we performed small-
molecule and small-interfering RNA (siRNA) screens of primary AML patient samples. In …
molecule and small-interfering RNA (siRNA) screens of primary AML patient samples. In …
The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
M Li, P Jiang, S Wei, J Wang, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Recent studies have revealed that tumor-associated macrophages are the most abundant
stromal cells in the tumor microenvironment and play an important role in tumor initiation …
stromal cells in the tumor microenvironment and play an important role in tumor initiation …
Impact of nanoparticle physicochemical properties on protein corona and macrophage polarization
Macrophages, the major component of the mononuclear phagocyte system, uptake and
clear systemically administered nanoparticles (NPs). Therefore, leveraging macrophages as …
clear systemically administered nanoparticles (NPs). Therefore, leveraging macrophages as …
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
Microenvironment contributes to follicular lymphoma (FL) pathogenesis and impacts survival
with macrophages playing a controversial role. In the present study, using FL primary …
with macrophages playing a controversial role. In the present study, using FL primary …